BeStock  
Stocks › ELVN

Enliven Therapeutics ELVN

US equityMarket cap rank #2407
$45.47 −$1.50 (-3.19%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $45.20 -0.59%
Open$46.94
Prev close$46.97
Day range$45.23 – $46.94
Volume821.5K
Market cap$3.33B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-27.6x
CheapRich

Near the bottom of its 5-year range · 20th percentile, 5-year average -14.9x

P/E over five years

-62x-40x-18x5xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$47.37
Price vs. fair value-4.0%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PE -27.56 -21.69 -14.86 20% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$47.37
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on ELVN.

Leave a comment

Scroll to Top